Literature DB >> 9356312

In vitro methylation of inorganic arsenic in mouse intestinal cecum.

L L Hall1, S E George, M J Kohan, M Styblo, D J Thomas.   

Abstract

The capacity of mouse intestinal cecal microflora to methylate inorganic arsenicals (iAs) was examined in vitro under conditions of restricted bacterial growth. Cecal contents incubated under anaerobic conditions at 37 degrees C for 21 hr methylated up to 40% of either 0.1 microM arsenite (iAsIII) or 0.1 microM arsenate (iAsV). Methylarsenic (MAs) was the predominant metabolite; however, about 3% of either substrate was converted to dimethylarsenic (DMAs). Over the first 6 hr, the rate of methylation was several times greater for iAsIII than for iAsV. There was a 3-hr delay in the production of methylated metabolites from iAsV, suggesting that reduction of iAsV to iAsIII before methylation could be rate limiting. Over the concentration range of 0.1 to 10 microM of iAsIII or iAsV, there was an approximately linear increase in the production of MAs and DMAs. There was evidence of saturation or inhibition of methylation at 100 microM of either substrate. Substrate concentration had little effect on MAs/DMAs ratio. Incubation of cecal contents at 0 degrees C abolished methylation of either arsenical. Under aerobic or anaerobic conditions, cecal tissue homogenates produced little MAs or DMAs from either arsenical. Addition of potential methyl group donors, L-methionine and methylcobalamin, into cecal contents significantly increased the rate of methylation, especially for iAsV. Addition of glutathione, but not L-cysteine, had a similar effect. Selenite, a recognized inhibitor of iAs methylation in mammalian tissues, inhibited methylation of either substrate by cecal contents. These data suggest that cecal microflora are a high capacity methylation system that might contribute significantly to methylation of iAs in intact animals. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9356312     DOI: 10.1006/taap.1997.8269

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  10 in total

Review 1.  Microbial methylation of metalloids: arsenic, antimony, and bismuth.

Authors:  Ronald Bentley; Thomas G Chasteen
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

2.  Comparison of bacterial diversity in proglacial soil from Kafni Glacier, Himalayan Mountain ranges, India, with the bacterial diversity of other glaciers in the world.

Authors:  T N R Srinivas; S M Singh; Suman Pradhan; M S Pratibha; K Hara Kishore; Ashish K Singh; Z Begum; S R Prabagaran; G S N Reddy; S Shivaji
Journal:  Extremophiles       Date:  2011-09-15       Impact factor: 2.395

3.  Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.

Authors:  Zuzana Drobna; Hua Naranmandura; Kevin M Kubachka; Brenda C Edwards; Karen Herbin-Davis; Miroslav Styblo; X Chris Le; John T Creed; Noboyu Maeda; Michael F Hughes; David J Thomas
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

4.  Effects of Mn(II) and Fe(II) on microbial removal of arsenic (III).

Authors:  Reena Amatya Shrestha; Bimala Lama; Jarina Joshi; Mika Sillanpää
Journal:  Environ Sci Pollut Res Int       Date:  2008-05-07       Impact factor: 4.223

5.  Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice.

Authors:  Klaus Michalke; Annette Schmidt; Britta Huber; Jörg Meyer; Margareta Sulkowski; Alfred V Hirner; Jens Boertz; Frank Mosel; Philip Dammann; Gero Hilken; Hans J Hedrich; Martina Dorsch; Albert W Rettenmeier; Reinhard Hensel
Journal:  Appl Environ Microbiol       Date:  2008-03-31       Impact factor: 4.792

6.  Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils.

Authors:  Tom Van de Wiele; Christina M Gallawa; Kevin M Kubachka; John T Creed; Nicholas Basta; Elizabeth A Dayton; Shane Whitacre; Gijs Du Laing; Karen Bradham
Journal:  Environ Health Perspect       Date:  2010-03-26       Impact factor: 9.031

7.  Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity.

Authors:  Xuefeng Ren; Maria Aleshin; William J Jo; Russel Dills; David A Kalman; Christopher D Vulpe; Martyn T Smith; Luoping Zhang
Journal:  Environ Health Perspect       Date:  2010-12-30       Impact factor: 9.031

8.  The role of gut microbiome and its interaction with arsenic exposure in carotid intima-media thickness in a Bangladesh population.

Authors:  Fen Wu; Liying Yang; Muhammad Tariqul Islam; Farzana Jasmine; Muhammad G Kibriya; Jebun Nahar; Bhaswati Barmon; Faruque Parvez; Golam Sarwar; Alauddin Ahmed; Mahbub Eunus; Tariqul Islam; Vesna Slavkovich; Jiyuan Hu; Huilin Li; Joseph H Graziano; Zhiheng Pei; Habibul Ahsan; Yu Chen
Journal:  Environ Int       Date:  2018-11-29       Impact factor: 13.352

9.  The Human Gut Microbiome's Influence on Arsenic Toxicity.

Authors:  Michael Coryell; Barbara A Roggenbeck; Seth T Walk
Journal:  Curr Pharmacol Rep       Date:  2019-11-25

10.  Exposure to Arsenite in CD-1 Mice during Juvenile and Adult Stages: Effects on Intestinal Microbiota and Gut-Associated Immune Status.

Authors:  Kuppan Gokulan; Matthew G Arnold; Jake Jensen; Michelle Vanlandingham; Nathan C Twaddle; Daniel R Doerge; Carl E Cerniglia; Sangeeta Khare
Journal:  MBio       Date:  2018-08-14       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.